Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Metzger Michael A sold 32,375 Syndax Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 9, 2026
On Jul 8, 2026, Metzger Michael A (Director, Chief Executive Officer) sold 32,375 Syndax Pharmaceuticals, Inc. shares at US$24.24 for US$785K under a trading plan, leaving 484,843 shares. Filed Jul 9, 2026 (Form 4).
- Sold
- 32,375 shares
- Price
- US$24.24
- Value
- US$785K
- Holding after
- 484,843 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Option exercise | 32,375 | US$6.38 | 517,218 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 32,375 | US$24.24 | 484,843 | Direct |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Metzger Michael A
- Syndax Pharmaceuticals, Inc. shareholders
- Form 4 · Metzger Michael A · Jun 2, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026